The insurability of nanomaterial production risk

Nature Nanotechnology

Volumn 8, Issue 4, 2013, Pages 222-224

  Mullins, Martin ^a   Murphy, Finbarr ^b   Baublyte, Lijana ^c   McAlea, Eamonn M ^a   Tofail, Syed A M ^c  

^a UNIVERSITY OF LIMERICK   (Ireland)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

NANOTECHNOLOGY;

PRODUCTION RISKS;

NANOSTRUCTURED MATERIALS;

NANOMATERIAL;

BIOTECHNOLOGICAL PRODUCTION; CHEMICAL COMPOSITION; DECISION MAKING; DRUG INDUSTRY; FUNDING; HUMAN; INSURANCE; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; POLICY; PRIORITY JOURNAL; REVIEW; RISK; RISK MANAGEMENT; SOLUBILITY; SURFACE CHARGE; WORK ENVIRONMENT;

EID: 84876356296     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2013.53     Document Type: Review

References (23)

1. Schofski, O. & Wegener, A. G. Te Geneva Papers on Risk and Insurance-Issues and Practice 24, 203-215 (2011).
2. Ferguson, N. Te Ascent of Money: A Financial History of the World (Penguin, 2008).
3. Roco, M. C., Mirkin, C. A. & Hersam, M. C. Nanotechnology Research Directions for Societal Needs in 2020: Retrospective and Outlook Vol. 1 (Springer, 2011).
4. Mangematin, V. & Walsh, S. Technovation 32, 157-160 (2012).
5. Kahan, D. M. et al. Nature Nanotech. 4, 87-90 (2008).
6. Chatterjee, R. Environ. Sci. Technol. 43, 1240-1241 (2009).
7. Murashov, V. & Howard, J. Nature Nanotech. 4, 467-470 (2009).
8. Malloy, T. F. ACS Nano 5, 5-12 (2011).
9. Murashov, V. & Howard, J. (eds) Nanotechnology Standards Ch. 9, 209-238 (Springer, 2011).
10. Murashov, V., Schulte, P., Geraci, C. & Howard, J. Ind. Health 49, 280-296 (2011).
11. Hett, A. Nanotechnology: Small Matter, Many Unknowns (Risk Perception Series) (Swiss Reinsurance Company, 2004); http://go.nature.com/9Dk87t
12. Johnson, E., Kostic, B., Riswadka, A. & Trodella, K. Insight on Nanotechnology (Zurich Financial Services Group, 2009); http://go.nature.com/ TUjuPB
13. Kostof, R. et al. J. Nanopart. Res. 8, 301-321 (2006).
14. Baxter, D. Nanotechnology: An Insurers Perspective (2008); http://go.nature.com/ZYiFgA
15. Nanotechnology CRO briefng Emerging Risks Initiative (Nanowerk, 2010); http://go.nature.com/vLPh2a
16. Monica, J. First Commercial Insurance Exclusion for Nanotechnology (Nanotechnology Law Report, 2008); http://go.nature.com/PylXW6
17. Fink, A. J. Proc. 2010 Nanotech Conf. 3, 583-586 (2010).
18. Zalk, D. M., Paik, S. Y. & Swuste, P. J. Nanopart. Res. 11, 1685-1704 (2009).
19. International Standards Organization ISO-TC229/TR11360:2010 Nanotechnologies-Methodology for the Classifcation and Categorization of Nanomaterials; http://go.nature.com/EaRazI
20. OECD Te Impacts of Nanotechnology on Companies: Policy Insights from Case Studies (OECD Working Party on Nanotechnology, 2010); http://doi.org/cq88td
21. Singer, P. A., Salamanca-Buentello, F. & Daar, A. S. Issues Sci. Technol. 21, 57-64 (2005).
22. Heinemann, M. & Schäfer, H. Hum. Exp. Toxicol. 28, 407-411 (2009).
23. Zhang, X. Q., Yin, L. H., Tang, M. & Pu, Y. P. Biomed. Environ. Sci. 24, 661-669 (2011).